BHC ▲ +32.3% - Bausch Health Companies Inc.
$BHC Third Quarter Consolidated Revenues of $2.94 billion, up 10% on a Reported basis and 8% on an Organic1 basis over the prior year period GAAP Net Income Attributable to Bausch Health of $436 million and GAAP Net Income of $446 million GAAP Earnings per Diluted Share Attributable to Bausch Health of $1.15 compared to $0.48 in the prior year period; Adjusted Earnings per Diluted Share1 of $1.77 compared to $1.16 in the prior year period, an increase of 53% Consolidated Adjusted EBITDA Attributable to Bausch Health1 of $1,305 million, up 32% over the prior year period
28-OCT-2026 04:02 PM ET
Share this post
More filings for $BHC
BHC ▲ +30.6% - Bausch Health Companies Inc.Oct 28, 2026BHC ▲ +30.6% - Bausch Health Companies Inc.Oct 28, 2026BHC ▲ +30.6% - Bausch Health Companies Inc.Oct 28, 2026BHC ▲ +32.3% - Bausch Health Companies Inc.Oct 28, 2026BHC ▼ -0.3% - Bausch Health Companies Inc.Oct 6, 2026BHC ▲ +0.6% - Bausch Health Companies Inc.Sep 8, 2026
View full $BHC filing history →💬 Comments
Loading comments…
Leave a comment
